利伐沙班拜瑞妥医保可以报销吗？

Xarelto is a small molecule oral anticoagulant jointly developed by Bayer and Johnson & Johnson. It can interrupt the endogenous and exogenous pathways of the coagulation waterfall by inhibiting factor Xa, inhibiting the generation of thrombin and thrombosis. Today we will learn more about whether rivaroxaban, Xarelto, can be reimbursed by medical insurance?

Rivaroxaban Xarelto is currently included in medical insurance. Specification: 10mg-5 tablets/box, priced at approximately $138; Specification: 15mg-7 tablets/box, priced at approximately $199; Specification: 20mg-7 tablets/box, priced at approximately $263$. Relatively speaking, the prices of rivaroxaban, German Bayer Xarelto 20mg*28 tablets and 15mg*28 tablets are around 350$, which is more suitable for patients. If necessary, you can buy abroad or obtain drugs through domestic professional overseas medical service organizations (such as medical companion tours) to ensure authenticity.

Rivaroxaban Xarelto mainly exerts its anticoagulant effect by inhibiting the activity of coagulation factor Xa, thereby reducing the generation of thrombin (coagulation factor IIa). It does not affect the activity of generated thrombin, so it has little impact on physiological hemostasis.

Rivaroxaban Xarelto is the world's first highly selective oral anticoagulant that directly inhibits Factor Factor Xa is the intersection of the extrinsic and intrinsic coagulation pathways and is a critical point in the coagulation process. Rivaroxaban is a highly selective and direct inhibitor of factor Xa activity, thereby inhibiting thrombin generation and thrombus formation. Currently, rivaroxaban has gradually replaced the old anticoagulant warfarin in the European market.

Rivaroxaban Xarelto was first launched in Canada in September 2008, and was approved by the European Union in October. It was marketed by Johnson & Johnson in the United States in July 2001. Currently, rivaroxaban has been approved in more than 100 countries around the world, and is marketed by Bayer in supermarkets. It has been successfully launched in 75 countries. In June 2009, rivaroxaban was officially launched in China under the trade name Xarelto. It is used to prevent or reduce the formation of blood clots, deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip or knee replacement surgery.

The above is the content of Xarelto Health Insurance, I hope it can help you!

Recommended related hot articles: /newsDetail/83302.html